Matches in Wikidata for { <http://www.wikidata.org/entity/Q104676737> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q104676737 description "clinical trial" @default.
- Q104676737 description "ensayo clínico" @default.
- Q104676737 description "ensayu clínicu" @default.
- Q104676737 description "klinisch onderzoek" @default.
- Q104676737 description "клінічне випробування" @default.
- Q104676737 description "կլինիկական փորձարկում" @default.
- Q104676737 description "临床试验" @default.
- Q104676737 name "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002" @default.
- Q104676737 name "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002" @default.
- Q104676737 type Item @default.
- Q104676737 label "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002" @default.
- Q104676737 label "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002" @default.
- Q104676737 prefLabel "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002" @default.
- Q104676737 prefLabel "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002" @default.
- Q104676737 P1050 Q104676737-B880A984-5D8D-4FE7-A230-1BF11BF1350A @default.
- Q104676737 P1132 Q104676737-C7501A50-456B-4846-8632-2A6AA1321675 @default.
- Q104676737 P1476 Q104676737-8EC0449F-1820-4544-B64F-F94684F9D8B1 @default.
- Q104676737 P17 Q104676737-3A70432B-D08D-46AA-BD7C-F656D4AAB45E @default.
- Q104676737 P2899 Q104676737-CA799826-78DB-4C37-9996-D6EACEAF0F60 @default.
- Q104676737 P3098 Q104676737-6D890F78-C96F-40FE-9095-3EB50E7A68F4 @default.
- Q104676737 P31 Q104676737-780E37DC-6734-49B6-BD5B-AC63C2BD36DB @default.
- Q104676737 P4135 Q104676737-E27B5019-AD73-4F73-8D12-C7CB6AC40D3C @default.
- Q104676737 P580 Q104676737-AF5C20AF-F9E9-4011-A80C-EC38A1D23946 @default.
- Q104676737 P582 Q104676737-EFEDDF29-037B-4194-9274-2B6B42FA60AE @default.
- Q104676737 P6099 Q104676737-39301345-D5D5-4ACD-8ED7-48ECB3D65BFC @default.
- Q104676737 P8005 Q104676737-377DF788-8173-441B-9B44-41F62FB4DBED @default.
- Q104676737 P8363 Q104676737-0478E544-3C7A-41CB-8517-03FA14EDB5CD @default.
- Q104676737 P1050 Q62736 @default.
- Q104676737 P1132 "+30" @default.
- Q104676737 P1476 "A Phase 1b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002 in Patients Who Have Pain Due to Moderate to Severe Osteoarthritis in a Hip and/or Knee Joint" @default.
- Q104676737 P17 Q408 @default.
- Q104676737 P2899 "+35" @default.
- Q104676737 P3098 "NCT04677933" @default.
- Q104676737 P31 Q30612 @default.
- Q104676737 P4135 "+65" @default.
- Q104676737 P580 "2020-06-03T00:00:00Z" @default.
- Q104676737 P582 "2020-12-22T00:00:00Z" @default.
- Q104676737 P6099 Q5452194 @default.
- Q104676737 P8005 Q76651189 @default.
- Q104676737 P8363 Q78089383 @default.